Compare Immunovant Inc. Common Stock (IMVT) vs Viking Holdings Ltd Ordinary Shares (VIK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Viking Holdings Ltd Ordinary Shares — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Viking Holdings Ltd Ordinary Shares trades at $81.62 (market cap $36.29B). The key difference: Viking Holdings Ltd Ordinary Shares is far larger — about 5.5× Immunovant Inc. Common Stock's market cap, and Viking Holdings Ltd Ordinary Shares is more actively traded (2,522,956 versus 1,131,364). Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Viking Holdings Ltd Ordinary Shares for 0 Days on average.
| IMVT | VIK | |
|---|---|---|
Market Cap | $6.62B | $36.29B |
Volume | 1,131,364 | 2,522,956 |
Sector | Health | Consumer Cyclical |
52-Week High | $44.96 | $108.26 |
52-Week Low | $17.03 | $57.08 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.72B | $38.67B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Viking Holdings Ltd Ordinary Shares
Viking operates river, ocean, and expedition cruises. Its itineraries focus on destination-based travel across Europe, the Americas, and other regions.
Read more on VIK →
